Literature DB >> 28797382

Precision Medicine Urgency: The Case of Inhaled Corticosteroids in COPD.

Samy Suissa1, Pierre Ernst2.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28797382     DOI: 10.1016/j.chest.2017.05.020

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

1.  The association between pre-hospital antibiotic therapy and subsequent in-hospital mortality in adults presenting with community-acquired pneumonia: an observational study.

Authors:  Biswajit Chakrabarti; Dan Wootton; Steven Lane; Elizabeth Kanwar; Joseph Somers; Jacyln Proctor; Nancy Prospero; Mark Woodhead
Journal:  Pneumonia (Nathan)       Date:  2018-03-25

Review 2.  Current appraisal of single inhaler triple therapy in COPD.

Authors:  Brian Lipworth; Chris RuiWen Kuo; Sunny Jabbal
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-09-28

3.  Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.

Authors:  Alan Kaplan; Kenneth R Chapman; Syed M Anees; Irvin Mayers; Driss Rochdi; Michel Djandji; David Préfontaine; Andrew McIvor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-01-18

Review 4.  Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short.

Authors:  Claudio Tantucci; Laura Pini
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-04-20

Review 5.  Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD.

Authors:  Anthony D'Urzo; Kenneth R Chapman; James F Donohue; Peter Kardos; M Reza Maleki-Yazdi; David Price
Journal:  Pulm Ther       Date:  2019-03-13

6.  Inhaled Corticosteroid Withdrawal in Chronic Obstructive Pulmonary Disease: Can IMPACT Help?

Authors:  Samy Suissa
Journal:  Am J Respir Crit Care Med       Date:  2020-11-01       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.